Search - tctmd.com

Displaying 1 - 20 of 76

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

Getting Ready for a Heart Failure Polypill, Well Before the Data Are In

Todd Neale

October 16, 2025

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Caitlin E. Cox

July 14, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

L.A. McKeown

June 05, 2025

News Daily News

AHA Statement Zeroes In On Sleep Health

L.A. McKeown

April 17, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Caitlin E. Cox

March 21, 2025

News Daily News

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Michael O'Riordan

March 03, 2025

News Daily News

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Yael L. Maxwell

February 25, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Getting Ready for a Heart Failure Polypill, Well Before the Data Are In

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

AHA Statement Zeroes In On Sleep Health

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Top Heart Failure News of 2024

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content